AU735751B2 - 5-(2-ethyl-2H-tetrazol-5-Y1)-1-methyl-1,2,3,6-tetrahydro pyridine maleate - Google Patents

5-(2-ethyl-2H-tetrazol-5-Y1)-1-methyl-1,2,3,6-tetrahydro pyridine maleate Download PDF

Info

Publication number
AU735751B2
AU735751B2 AU81020/98A AU8102098A AU735751B2 AU 735751 B2 AU735751 B2 AU 735751B2 AU 81020/98 A AU81020/98 A AU 81020/98A AU 8102098 A AU8102098 A AU 8102098A AU 735751 B2 AU735751 B2 AU 735751B2
Authority
AU
Australia
Prior art keywords
acid addition
addition salt
maleic acid
ethyl
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU81020/98A
Other languages
English (en)
Other versions
AU8102098A (en
Inventor
Michael Bech Sommer
Ole Nielsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
H Lundbeck AS
Original Assignee
H Lundbeck AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H Lundbeck AS filed Critical H Lundbeck AS
Publication of AU8102098A publication Critical patent/AU8102098A/en
Application granted granted Critical
Publication of AU735751B2 publication Critical patent/AU735751B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU81020/98A 1997-07-01 1998-07-01 5-(2-ethyl-2H-tetrazol-5-Y1)-1-methyl-1,2,3,6-tetrahydro pyridine maleate Ceased AU735751B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK78197 1997-07-01
DK781/97 1997-07-01
PCT/DK1998/000294 WO1999001448A1 (fr) 1997-07-01 1998-07-01 Maleate de 5-(2-ethyl-2h-tetrazole-5-yl)-1-methyle-1,2,3,6-tetrahydropyridine

Publications (2)

Publication Number Publication Date
AU8102098A AU8102098A (en) 1999-01-25
AU735751B2 true AU735751B2 (en) 2001-07-12

Family

ID=8097489

Family Applications (1)

Application Number Title Priority Date Filing Date
AU81020/98A Ceased AU735751B2 (en) 1997-07-01 1998-07-01 5-(2-ethyl-2H-tetrazol-5-Y1)-1-methyl-1,2,3,6-tetrahydro pyridine maleate

Country Status (25)

Country Link
EP (1) EP0994869A1 (fr)
JP (1) JP2002507215A (fr)
KR (1) KR20010014297A (fr)
CN (1) CN1261361A (fr)
AR (1) AR013096A1 (fr)
AU (1) AU735751B2 (fr)
BG (1) BG103933A (fr)
BR (1) BR9810331A (fr)
CA (1) CA2293324A1 (fr)
CO (1) CO4940483A1 (fr)
EA (1) EA200000081A1 (fr)
HU (1) HUP0002876A2 (fr)
IL (1) IL133093A0 (fr)
IS (1) IS5278A (fr)
JO (1) JO2031B1 (fr)
MA (1) MA25138A1 (fr)
NO (1) NO996580D0 (fr)
PE (1) PE116099A1 (fr)
PL (1) PL337184A1 (fr)
SK (1) SK187399A3 (fr)
TN (1) TNSN98120A1 (fr)
TR (1) TR199903283T2 (fr)
UY (2) UY25069A1 (fr)
WO (1) WO1999001448A1 (fr)
ZA (1) ZA985498B (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8714789D0 (en) * 1987-06-24 1987-07-29 Lundbeck & Co As H Heterocyclic compounds
JPH11514654A (ja) * 1995-11-06 1999-12-14 ハー・ルンドベック・アクチェゼルスカベット 外傷による脳損傷の治療方法

Also Published As

Publication number Publication date
EA200000081A1 (ru) 2000-08-28
TNSN98120A1 (fr) 2005-03-15
AU8102098A (en) 1999-01-25
PL337184A1 (en) 2000-08-14
HUP0002876A2 (hu) 2001-06-28
MA25138A1 (fr) 2001-04-02
WO1999001448A1 (fr) 1999-01-14
IS5278A (is) 1999-11-30
AR013096A1 (es) 2000-12-13
NO996580L (no) 1999-12-30
UY25069A1 (es) 1998-12-21
ZA985498B (en) 1999-01-20
KR20010014297A (ko) 2001-02-26
CO4940483A1 (es) 2000-07-24
SK187399A3 (en) 2000-06-12
NO996580D0 (no) 1999-12-30
BR9810331A (pt) 2000-09-05
EP0994869A1 (fr) 2000-04-26
TR199903283T2 (xx) 2000-06-21
CA2293324A1 (fr) 1999-01-14
UY25177A1 (es) 2000-12-29
BG103933A (en) 2000-07-31
IL133093A0 (en) 2001-03-19
JO2031B1 (en) 1999-05-15
CN1261361A (zh) 2000-07-26
PE116099A1 (es) 1999-11-23
JP2002507215A (ja) 2002-03-05

Similar Documents

Publication Publication Date Title
CN101031548B (zh) N-(4-氟苄基)-n-(1-甲基哌啶-4-基)-n'-(4-(2-甲基丙氧基)-苯基甲基)脲的盐及其制备
ES2229342T3 (es) Sales de mesilato de 5-(2-(4-(1,2-benzoisotiazol-3-il)-1-piperazinil)etil)-6-cloro-1,3-dihidro-2h-indol-2-ona(=ziprasidona),su preparacion y uso como antagonista de dopamina d2.
EP0610793A1 (fr) Dérivés de morpholine tétracycliques et leur utilisation comme analgésiques
JPH054983A (ja) イソキノリノン誘導体、その製造方法およびその誘導体を有効成分として含有する５−ｈｔ３ レセプター拮抗剤
JPH09500875A (ja) タキキニン拮抗薬としての４−フェニル−４−フェニルプロピル（エチル）−ピペリジン
CH695216A5 (de) Verfahren zur Herstellung eines nicht hydratisierten Salzes eines Piperidinderivats und eine so erhältliche neue kristalline Form eines solchen Salzes.
WO2004092137A1 (fr) Nouvelles formes cristallines de chlorhydrate de donepezil
MXPA03005888A (es) Base libre de amlodipina.
JPH05506249A (ja) ビスーベンゾシクロヘプタピペリジリデン、ピペリジンおよびピペラジン化合物、組成物および使用法
JPH09510222A (ja) ２，３，４，５−テトラヒドロ−１ｈ−３−ベンゾアゼピン化合物の酸付加塩
AU735751B2 (en) 5-(2-ethyl-2H-tetrazol-5-Y1)-1-methyl-1,2,3,6-tetrahydro pyridine maleate
DE69822937T2 (de) Indolmorphinan-derivate und medikamente zur behandlung/mittel zur vorbeugung von cerebralen störungen
CA2164296C (fr) Chimie heterocyclique
JP2002511466A (ja) マレイン酸パロキセチン
MXPA03005884A (es) Hemimaleato de amlodipina.
EP0523013B1 (fr) Utilisation des dérivés de l'acide benzimidazoline-2-oxo-1-carboxylique dans le traitement des maladies mentales organiques
US7335380B2 (en) Amlodipine free base
MXPA99011450A (en) 5-(2-ethyl-2h
CZ477899A3 (cs) 5-(2-ethyI-2H-tetrazol-5-yl)-l-methyl-l,2,3,6- tetrahydropyridinmaleátová adiční sůl
JPH08507758A (ja) 薬理活性を有するアミド化合物
EP1355632B1 (fr) Base libre d'amlodipine
JPH04270222A (ja) 脳機能改善剤
JP2719063B2 (ja) 置換３−アミノキヌクリジンｐ物質拮抗剤
WO2002085910A1 (fr) Formes polymorphes de n-(2,3-dimethyl-5,6,7,8-tetrahydrofuro[2,3-b]quinolin-4-yl)-2-(2- oxopyrrolidin -1 -yl)acetamide
CA2101933A1 (fr) Agents neuroprotecteurs

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired